Abstract:Objective To explore the role of toll-like receptor 4 (TLR4)/NF-κB signaling pathway in acute necrotizing pancreatitis (ANP)-associated lung injury and the intervention of lipoxin A4 (LXA4) analogue.Methods Forty-five Sprague-Dawley rats were randomly(random number)divided into the sham operation group,experimental group,and intervention group,each group containing 15 rats.ANP animal models were prepared by injecting sodium taurocholate into biliopancreatic tube in the experimental group.No sodium taurocholate was injected into biliopancreatic duct in the sham operation group.After the preparation of ANP animal models in the intervention group,LXA4 was injected through the tail vein.Rats in each group were randomly divided into 3 subgroups (n=5 each subgroup).The serum amylase,TNF-α,IL-1β,IL-6 and endotoxin levels were detected 6,12 and 24 h after the operation.The lung injury scores were assessed and the lung wet/dry weight ratio was calculated.The expressions of TLR4 and NF-rκB p65 in lung tissues were detected by Western blot.Results Serum levels of amylase,TNF-α,IL-1β,IL-6 and endotoxin in the experimental and intervention groups were significantly higher than those in the sham operation group,while the levels of the above indicators in the intervention group was significantly lower than those in the experimental group,and the differences were statistically significant (P＜0.05).Postoperative lung injury scores and lung wet/dry weight ratio in the experimental group were significantly higher than those in the sham operation group,and the differences were statistically significant (P＜0.05).Lung injury scores in the intervention group 6 h after operation had no significant difference compared with those in the sham operation group (P ＞ 0.05),while lung wet/dry weight ratio in the intervention group 6 h after operation,and lung injury scores and lung wet/dry weight ratio in the intervention group 12 h or 24 h respectively after operation were significantly higher than those in the sham operation group,with statistically significant differences (P＜0.05).Postoperative lung injury scores and lung wet/dry weight ratio in the intervention group were significantly lower than those in the experimental group,and the differences were statistically significant (P＜0.05).The expressions of TLR4 and p65 in the lung tissues of the experimental and intervention groups were significantly higher than those of the sham operation group,and the expressions of TLR4 and p65 in the lung tissues of the intervention group were significantly lower than those of the experimental group,with statistically significant differences (P＜0.05).Conclusions LXA4 can reduce the severity of acute necrotizing pancreatitis-associated lung injury,and its mechanism is related to reducing the stimulation of endotoxin,thus inhibiting TLR4 signaling pathway and the activation of p65 to down-regulate the level of pro-inflammatory cytokines.

Lipoxin A4Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer

Lipoxin A4 Reverses Mesenchymal Phenotypes to Attenuate Invasion and Metastasis Via the Inhibition of Autocrine TGF-β1 Signaling in Pancreatic Cancer.

Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression

BML-111, the lipoxin A4 agonist, modulates VEGF or CoCl2-induced migration, angiogenesis and permeability in tumor-derived endothelial cells

Apolipoprotein A-I Mimetic Peptide L-4F Suppresses Granulocytic-Myeloid-Derived Suppressor Cells in Mouse Pancreatic Cancer

NAP1051, a Lipoxin A4 Biomimetic Analogue, Demonstrates Antitumor Activity Against the Tumor Microenvironment

Lipid mediator lipoxin A4 and its analog BML-111 exert antitumor effects in melanoma

A Novel Small Molecular Prostaglandin Receptor EP4 Antagonist, L001, Suppresses Pancreatic Cancer Metastasis

Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer

Xanthatin Suppresses Pancreatic Cancer Cell Growth via the ROS/RBL1 Signaling Pathway: In Vitro and In Vivo Insights

Effects of Lipoxin A<sub>4</sub> on CoCl<sub>2</sub>-Induced Angiogenesis and Its Possible Mechanisms in Human Umbilical Vein Endothelial Cells

Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, Invasion, and Angiogenesis in Pancreatic Cancer Cells

Expression of Toll-Like Receptor 4/Nf-Κb Signaling Pathway in Acute Necrotizing Pancreatitis-Associated Lung Injury and Intervention of Lipoxin A4 Analogue

A Lipid-Sensitive Spider Peptide Toxin Exhibits Selective Anti-Leukemia Efficacy through Multimodal Mechanisms

Application of MicroRNA-124-Loaded Liposome Nanoparticles for Suppressing Pancreatic Cancer Cell Progression and Restraining Autophagy Through Targeting BECN1

Resveratrol Inhibits Hypoxia-Driven ROS-induced Invasive and Migratory Ability of Pancreatic Cancer Cells Via Suppression of the Hedgehog Signaling Pathway.

Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss

ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis

Schizandrin A suppressed pancreatic cancer growth by inhibiting COX-2/ALOX5 shunting.

Retraction Note To: Lupeol Inhibits Proliferation and Induces Apoptosis of Human Pancreatic Cancer PCNA-1 Cells Through AKT/ERK Pathways

Effect of 5-Lipoxygenase and 12-Lipoxygenase on Proliferation and Apoptosis of Pancreatic Cancer Cell